Endometrial Neoplasms: all 1,347 studies
Page 11 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.
- Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian CancersStatus unknownNCT03112733
- Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer SurvivorsSuspendedNCT03095664Not applicable
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid TumorsSuspendedNCT03065062Phase 1
- Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial CancerWithdrawnNCT03042897Not applicable
- Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight LossCompletedNCT03027479Not applicable
- Study of Niraparib and TSR-042 in Recurrent Endometrial CancerActive, not recruitingNCT03016338Phase 2
- A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaActive, not recruitingNCT03008408Phase 2
- Lenvatinib in Second Line Endometrial CarcinomaWithdrawnNCT03005015Phase 2
- HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeStatus unknownNCT03000192
- Fluorescence for Sentinel Lymph Node Identification in Cancer SurgeryCompletedNCT02997553Phase 3
- Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial CancerStatus unknownNCT02990728Phase 2
- Endometrial Cancer Diet and ExerciseCompletedNCT02987881Not applicable
- Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial CancerCompletedNCT02987777
- Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast CancerCompletedNCT02983279Not applicable
- A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaStatus unknownNCT02982486Phase 2
- First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid TumorsCompletedNCT02977195Phase 1
- Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial CancerCompletedNCT02943811
- A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerCompletedNCT02922764Phase 1
- Carboplatin-cyclophosphamide Combined With AtezolizumabCompletedNCT02914470Phase 1
- Prevalence of Self Reported Lymphedema in Patients With Endometrial CancerCompletedNCT02912767
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic IndicationsCompletedNCT02865889
- Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.CompletedNCT02852954
- Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial CancerCompletedNCT02834988
- Endometrial Cancer and Array CGHCompletedNCT02833896
- SLNM in Endometrial Cancer Combined With OSNACompletedNCT02826291
- Sentinel Node Mapping in Women With Cervical and Endometrial CancerCompletedNCT02825355
- A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic CancersCompletedNCT02824328
- The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine CancerStatus unknownNCT02822833Not applicable
- Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerCompletedNCT02788708Phase 1
- Endometrial Cancer and Fractalkine-receptor Axis of FractalkineCompletedNCT02774395
- A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the EndometriumCompletedNCT02767362Early Phase 1
- Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial CancerTerminatedNCT02765698
- Role of Uterine Manipulator in Hysterectomy - Ro.Man.HYStatus unknownNCT02762214Phase 3
- Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsCompletedNCT02755844Phase 1/2
- Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)Active, not recruitingNCT02730923Phase 1/2
- Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial CancerCompletedNCT02730429Phase 2
- Combination Chemotherapy With Nintedanib / Placebo in Endometrial CancerCompletedNCT02730416Phase 2
- Pilot Study of Durvalumab and Vigil in Advanced Women's CancersCompletedNCT02725489Phase 2
- Studies of the Tumour Suppressor Gene PTEN - Endometrial CancerCompletedNCT02724501
- MR-HIFU for Recurrent Gynaecological CancerCompletedNCT02714621Not applicable
- Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal FluidsWithdrawnNCT02704650Not applicable
- Translating Healthy Lifestyle Interventions for Cancer SurvivorsCompletedNCT02690766Not applicable
- Sentinel Lymph Node Detection in Endometrial CancerCompletedNCT02690259Not applicable
- Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid TumorsStatus unknownNCT02684318Phase 1/2
- STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian CancerCompletedNCT02676726Not applicable
- Cancer of the Uterus and Treatment of Stress Urinary IncontinenceStatus unknownNCT02667431
- Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial CancerTerminatedNCT02665962Not applicable
- Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative ConsultationActive, not recruitingNCT02658565Not applicable
- Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsCompletedNCT02646748Phase 1
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial CancersStatus unknownNCT02638402
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Active, not recruitingNCT02628067Phase 2
- Advanced Methods for Cancer Detection by Vaginal ScreeningCompletedNCT02622776Not applicable
- Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsCompletedNCT02611024Phase 1/2
- Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the EndometriumTerminatedNCT02589366Phase 1
- Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)Active, not recruitingNCT02584478Phase 3
- Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoStatus unknownNCT02580747Phase 1
- Physical Activity Behavioral Intervention in Obese Endometrial Cancer SurvivorsCompletedNCT02575872Not applicable
- Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)TerminatedNCT02566811Not applicable
- Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial CancerCompletedNCT02564276Phase 3
- Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer PatientsStatus unknownNCT02560571Phase 2
- Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)TerminatedNCT02558348Phase 1/2
- Use of the Sentinel Node Biopsy for Early Endometrial Cancer.Status unknownNCT02545348
- The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal PeriodStatus unknownNCT02512848
- Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian CancerActive, not recruitingNCT02494791Not applicable
- Open-label Phase 1b Study of ARQ 092 in Combination With AnastrozoleTerminatedNCT02476955Phase 1
- TREC Lifestyle Beyond Cancer Study in Endometrial Cancer SurvivorsCompletedNCT02466061Not applicable
- Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer SurvivorsCompletedNCT02465541Not applicable
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of MalignanciesStatus unknownNCT02433626Phase 1
- ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?CompletedNCT02413606Not applicable
- LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial CarcinomaCompletedNCT02387645Not applicable
- Improved Method of Detecting Cancer MetastasesStatus unknownNCT02368067Not applicable
- Exercise as an Intervention in Endometrial Cancer SurvivorsStatus unknownNCT02367950Not applicable
- Hula, a Physical Activity Intervention for Female-Cancer SurvivorsCompletedNCT02351479Not applicable
- Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical HyperplasiaCompletedNCT02342730Not applicable
- Lymph Node Counts in Endometrial Cancer StagingCompletedNCT02335775
- 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized TrialCompletedNCT02320565Not applicable
- Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial CancerActive, not recruitingNCT02285192Phase 1
- Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial CancersCompletedNCT02269293Phase 1
- Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsCompletedNCT02262455Phase 1
- Linking Obesity and Estrogen-responsive Genes in Endometrial CancerCompletedNCT02226302
- Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.CompletedNCT02221076Not applicable
- Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial CancerStatus unknownNCT02188550Phase 2
- Biomarkers for Gynecologic CancerStatus unknownNCT02178462
- Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer SurvivorsCompletedNCT02135562Not applicable
- Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial CancerCompletedNCT02131558Not applicable
- A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncerWithdrawnNCT02127151Phase 2
- Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian CancerWithdrawnNCT02117817Phase 1
- Lymphedema After Primary Surgery for Endometrial CancerCompletedNCT02115477
- POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With TemsirolimusCompletedNCT02093598Phase 2
- Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290CompletedNCT02093546
- 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological BrachytherapyCompletedNCT02091050Phase 2
- Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid TumorCompletedNCT02069158Phase 1
- Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CAStatus unknownNCT02064725Phase 2
- Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing BrachytherapyCompletedNCT02058550Phase 1
- A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerTerminatedNCT02042885Phase 1/2
- Endometrial Cancer Biomarker Changes Following Exposure to MetforminWithdrawnNCT02042495Phase 2